Naming matters because BPC-157 appears in literature as BPC 157, pentadecapeptide BPC 157, gastric pentadecapeptide, and stable gastric pentadecapeptide BPC 157
BPC-157 is not FDA-approved for human use, and insurance carriers do not reimburse off-label peptide therapy
The danger zone is real: BPC-157 reduces pain and inflammation quickly, often within weeks 1 to 4
Users may experience a boost in energy within a few days of use
Many thanks to my brilliant co-authors for making this possible: Yasmeen Abdel Bari, Katharine Lynch-Kelly, Danish Hafeez, Livia Asan, Mark J Edwards, Dr Gertrude (Trudi) Seneviratne OBE (she/her), Thomas A Pollak #HyperemesisGravidarum #PerinatalMentalHealth #WomensHealth #ObGyn #Psychiatry #PerinatalPsychiatry To view or add a comment, sign in SSRIs & Brain Fertilizer: How They Boost BDNF Did you know your brain has its own fertilizer